JOANN COLMAN: Open Payments
NPI 1457790263 · GLOUCESTER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 40 payments from 16 companies in 2025. Trend: 2023 $1,006 · 2024 $1,196 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $262 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Exact Sciences Corporation | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Lundbeck LLC | 2 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| Almatica Pharma LLC | 2 | $30 |
Products named: FARXIGA, REXULTI, AIRSUPRA, Cologuard Collection Kit, XIFAXAN, TRELEGY ELLIPTA, AUSTEDO XR, LOREEV XR.
Industry payments across NJ — which companies pay providers there.
